---
$id: https://graph.org.ai/products/commodity/51101676
$type: Product
source: UNSPSC
code: "51101676"
title: "Parvaquone"
class: "51101600"
classTitle: "Amebicides and trichomonacides"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Parvaquone

**UNSPSC Code**: 51101676
**Class**: [Amebicides and trichomonacides](Amebicides and trichomonacides.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimalarial agent with the molecular formula C16H16O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A2BH18685W, chemically known as 1,4-naphthalenedione, 2-cyclohexyl-3-hydroxy- but generally known as parvaquone, which bears US NIH Compound Identifier 71825. European Medicines Agency schedules Parvaquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09634MIG. The term PARVAQUONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). PARVAQUONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule parvaquone under HS 29146990 and SITC 51629. As of Q4 2014, PARVAQUONE remains the US FDA Preferred Term for this commodity. Parvaquone bears US NLM identifiers UMLS ID C0070129 and NCI Concept Code C66327. SMILES: OC1=C(C2CCCCC2)C(=O)C(=O)C2C1CCCC2.

